France· FR:66958808
ZYKADIA 150 mg, gélule
A medicinal product containing céritinib, registered in France by NOVARTIS EUROPHARM (IRLANDE), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CÉRITINIB
- Manufacturer
- NOVARTIS EUROPHARM (IRLANDE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400930146118plaquette(s) thermoformée(s) PVC polychlortrifluoroéthylène aluminium de 90 gélule(s)EUR 3.77
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Céritinib in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaZYKADIANovartis Europharm Limited, Dublin
- CanadaZYKADIANOVARTIS PHARMACEUTICALS CANADA INC
- SpainZYKADIA 150 MG CAPSULAS DURASNovartis Europharm Limited
- FinlandZykadiaNovartis Europharm Limited
- United KingdomZykadia 150mg capsulesNovartis Pharmaceuticals UK Ltd
- IrelandZykadia 150 mg hard capsulesNovartis Europharm Limited
- IcelandZykadiaNovartis Europharm Limited*
- NetherlandsZykadia 150 mg harde capsulesNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Zykadia
- Liechtenstein · Zykadia
- Norway · Zykadia
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/356523b1-2a15-43ac-bea1-0772fe1b922b GET /v1/drugs/356523b1-2a15-43ac-bea1-0772fe1b922b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "66958808",
"date_amm": "2015-05-06",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/15/999",
"substance": "CÉRITINIB",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "gélule",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about céritinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.